Table 1

Baseline characteristics of the study population

Baseline characteristicsTotal (n=697)Subgroup 1 (n=330) ‘good outcome’Subgroup 2 (n=257) ‘moderate outcome’Subgroup 3 (n=110) ‘poor outcome’
Demographics
 Age (years)56.0±5.156.2±5.255.8±5.255.6±4.8
 Female, no. (%)567 (81.3)262 (79.4)213 (82.9)92 (83.6)
 Body mass index (kg/m2)26.6±4.325.5±3.627.4±4.428.0±4.9
Clinical signs and symptoms
 NRS for knee pain (range 0–10)3.7±2.12.9±1.94.0±1.85.4±1.8
 Bilateral knee pain, no. (%)399 (57.2)184 (55.8)141 (54.9)74 (67.3)
 Clinical knee OA, no. (%)606 (86.9)279 (84.5)223 (86.8)104 (94.5)
 Morning stiffness knee, no. (%)497 (71.3)218 (66.1)187 (72.8)92 (83.6)
 Bony tenderness, no. (%)365 (52.4)145 (43.9)146 (56.8)74 (67.3)
 Crepitus, no. (%)367 (52.7)178 (53.9)126 (49.0)63 (57.3)
 Active knee flexion range (degrees)133.3±10.0135.2±9.0132.4±9.7130.0±12.3
 Total knee replacement after 5-year follow-up, no. (%)12 (1.7)2 (0.6)5 (1.9)5 (4.5)
 Hip pain, no. (%)348 (49.9)133 (40.3)144 (56.0)71 (64.5)
 Total hip replacement after 5-year follow-up, no. (%)10 (1.4)1 (0.3)4 (1.6)5 (4.5)
Radiographic features
 KL grade=0, no. (%)295 (42.3)155 (47.0)94 (36.6)46 (41.8)
 KL grade=1, no. (%)321 (46.1)150 (45.5)117 (45.5)54 (49.1)
 Osteophytosis, no. (%)122 (17.5)51 (15.5)44 (17.1)27 (24.5)
 Joint space narrowing, no. (%)107 (15.4)40 (12.1)42 (16.3)25 (22.7)
Comorbidity count, no. (%)
 0166 (23.8)100 (30.3)52 (20.2)14 (12.7)
 1205 (29.4)107 (32.4)73 (28.4)25 (22.7)
 2151 (21.7)76 (23.0)57 (22.2)18 (16.4)
 ≥ 3162 (23.2)44 (13.3)70 (27.2)48 (43.6)
WOMAC data
 WOMAC pain (range 0–20)5.3±3.43.5±2.76.0±2.79.0±2.9
 WOMAC stiffness (range 0–8)2.8±1.62.1±1.43.1±1.44.4±1.5
 WOMAC function (range 0–68)16.8±11.69.8±7.419.5±8.532.7±10.2
Psychological factors
 SF-36 vitality (range 0–100)63.4±16.868.5±14.561.6±16.551.9±17.3
 PCI resting (range 5–20)9.3±2.58.7±2.49.4±2.410.9±2.7
  • Values are presented as mean±SD unless otherwise indicated.

  • KL grade, Kellgren and Lawrence grade; NRS, numeric rating scale; OA, osteoarthritis; PCI, Pain Coping Inventory; SF-36, Short-Form 36 Health Survey; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.